CompoAtlas

H.PYLORI CONTROLE

Food supplement declared in France, decision dated 11 November 2026

H.PYLORI CONTROLE, from CENTRE DE RECHERCHES PHYTOTHERAPIQUES, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: acétylcystéine 240 mg per day, Lactobacillus Reuteri LACTOBACILLUS REUTERI 40,000,000,000 (unit not declared) per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
CENTRE DE RECHERCHES PHYTOTHERAPIQUES
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2 GELULES PAR JOUR
Directions for use
Prendre une gélule matin et soir avec un verre d’eau.
Intended populations
Men and women aged 18 and over, People over 60
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 382122, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
acétylcystéine240 mg

Micro-organisms

StrainPer day
Lactobacillus Reuteri LACTOBACILLUS REUTERI40,000,000,000 (unit not declared)

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne peut remplacer une alimentation variée et équilibrée et un mode de vie sain. Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière conseillée. Conserver à l’abri de la chaleur, dans un endroit propre et sec.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • acétylcystéine
    Read the warning, when it applies and the studies cited

    N-ACETYL-L-CYSTEINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).

    Sources cited by Health Canada (2)
    • Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
    • Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed

    Contraindications

    Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).

    Sources cited by Health Canada (4)
    • Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
    • Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
    • Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
    • Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “H.PYLORI CONTROLE: composition and regulation”, https://compoatlas.com/en/supplements/products/382122-h-pylori-controle, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line